Truist raised the firm’s price target on Arthur J. Gallagher to $270 from $255 and keeps a Buy rating on the shares. The company’s Q3 results were “solid”, with “robust” M&A activity also set to position Arthur J. Gallagher for health growth in 2024, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AJG:
- Arthur J. Gallagher names Patrick Gallagher as COO
- Arthur J. Gallagher & Co. Announces Third Quarter 2023 Financial Results
- Arthur J. Gallagher reports Q3 adjusted EPS $2.00, consensus $1.95
- ARTHUR J. GALLAGHER & CO. ANNOUNCES REGULAR FOURTH QUARTER DIVIDEND
- Arthur J. Gallagher & Co. Signs Agreement to Acquire Cadence Insurance, Inc.